ScienceCloses Jan 1 · Results Jan 2
Will the experimental pancreatic cancer drug daraxonrasib be approved by the FDA by December 31, 2026?
29%
Stable · last 24h
📊 0 bettors💎 0 at stake
Your stake
💎10
Potential payout
—
🤖 Context
YES if the U.S. Food and Drug Administration officially grants marketing approval for daraxonrasib by December 31, 2026; NO otherwise.
🔍 Sources
Sources used to create this market
💬 0 comments
Add your take...No comments yet. Start the conversation!